Colorectal Cancer | Specialty

The OncLive Colorectal Cancer condition center page is a comprehensive resource for clinical news and expert insights on colorectal cancer treatment and management, with a focus on novel therapeutic strategies including checkpoint inhibitors and TKIs across lines of therapy. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in colorectal cancer.

FDA Grants Novel Triplet Breakthrough Designation in BRAF+ mCRC

August 7th 2018

The FDA has granted a breakthrough therapy designation to the combination of encorafenib (Braftovi), binimetinib (Mektovi), and cetuximab (Erbitux) for the treatment of patients with BRAF V600E–mutant metastatic colorectal cancer.

Dr. Bekaii-Saab Reflects on the Findings of the ReDOS Trial in mCRC

August 7th 2018

Tanios Bekaii-Saab, MD, professor of medicine, Mayo Clinic, reflects on the findings from the ReDOS study in patients with metastatic colorectal cancer.

Dr. Choti on the Role of Surgery in Rectal Cancer

August 2nd 2018

Michael A. Choti, MD, chief of surgery, Banner MD Anderson Cancer Center, discusses the role of surgery in the treatment of patients with rectal cancer.

Healthy Lifestyle and Improved Survival Benefit in CRC

July 30th 2018

Adjuvant Therapy for Stage 2/3 Colorectal Cancer

July 30th 2018

Immunotherapy Combinations in MSI and MSS mCRC

July 30th 2018

Sequencing and Dosing for Refractory Colon Cancer

July 30th 2018

Management of Regional Colorectal Cancer Metastases

July 30th 2018

Treatment of BRAF-Mutated Metastatic Colorectal Cancer

July 30th 2018

Second-Line PFS With Combination Biologics in mCRC

July 30th 2018

mCRC: Right-Side vs Left-Side Tumors

July 30th 2018

EGFR-Targeted Therapy in Metastatic Colorectal Cancer

July 30th 2018

Next-Generation Sequencing for Metastatic CRC

July 30th 2018

Locally Advanced Rectal Cancer: PROSPECT Trial

July 30th 2018

Postoperative Chemotherapy for Advanced Rectal Cancer

July 30th 2018

Recent Clinical Trial Data in Locally Advanced CRC

July 30th 2018

Tumor Assessment and Individualized Treatment for CRC

July 30th 2018

Standard of Care for Locally Advanced CRC

July 30th 2018

Updates in Screening Guidelines for CRC

July 30th 2018

The Rising Incidence of Early-Onset CRC: What Do We Know and What Can We Do?

July 24th 2018

During an OncLive Peer Exchange® program on individualizing treatment and improving outcomes for patients with CRC, a panel of experts shared their insights on early-onset CRC, which has been observed to occur as early as adolescence.